# SUMATRIPTAN SUCCINATE
> **ANDA206019** · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2025-07-15
## Drug
- **FDA Application Number:** ANDA206019
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN SUCCINATE
- **Generic name:** Sumatriptan Succinate
- **Active ingredients:** SUMATRIPTAN SUCCINATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IPCA LABS LTD
- **First approval:** 2025-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206019)
---
*MORVS · CC0 1.0*